ONC
BeOne Medicines Ltd.
+4.82 (+1.38%)352.90USD107K成交股數522B市值802.0本益比(近四季)85.1股價營收比+29.6%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.7B+53% | 1.5B+34% | 1.4B+41% | 1.3B+42% | 1.1B+49% | 1.1B+44% | 1.0B+68% | 929M+107% | 752M | 781M | 595M | 448M |
| 營業成本 | – | – | – | – | – | – | – | – | – | 96.3M | 96.0M | 81.8M |
| 毛利 | 1.5B+61% | 1.3B+39% | 1.2B+46% | 1.2B+45% | 952M+52% | 967M+41% | 831M+66% | 791M+116% | 627M | 685M | 499M | 366M |
| 毛利率 | 89.8% | 89.0% | 86.1% | 87.5% | 85.2% | 85.8% | 83.0% | 85.1% | 83.4% | 87.7% | 83.9% | 81.7% |
| 研發費用 | 612M | 541M | 524M | 525M | 482M | 542M | 496M | 454M | 461M | 453M | 423M | 409M |
| 銷售管理費用 | 593M | 555M | 529M | 538M | 459M | 505M | 455M | 444M | 427M | 366M | 395M | 328M |
| 營業利益 | 325M+2828% | 250M-415% | 163M-236% | 87.9M-182% | 11.1M-104% | −79.4M-41% | −120M-62% | −107M-71% | −261M | −134M | −319M | −371M |
| 營業利益率 | 19.1% | 16.5% | 11.5% | 6.7% | 1.0% | -7.0% | -12.0% | -11.5% | -34.8% | -17.1% | -53.5% | -82.9% |
| 稅後淨利 | 237M+18562% | 227M-250% | 125M-203% | 94.3M-178% | 1.3M-101% | −152M-171% | −121M-68% | −120M-65% | −251M | 215M | −381M | −348M |
| 淨利率 | 13.9% | 15.0% | 8.8% | 7.2% | 0.1% | -13.5% | -12.1% | -13.0% | -33.4% | 27.6% | -64.0% | -77.8% |
| 稀釋 EPS | 0.16 | 0.15-250% | 0.08-189% | 0.06-167% | 0.00-100% | -0.10-167% | -0.09-68% | -0.09-65% | -0.19 | 0.15 | -0.28 | -0.26 |
| 稀釋股數 | 1.51B | 1.51B | 1.49B | 1.46B | 1.45B | 1.37B | 1.38B | 1.36B | 1.36B | 1.39B | 1.36B | 1.35B |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 5.1B | 4.8B | 4.0B | 2.8B | 2.5B | 2.6B | 2.7B | 2.6B | 2.8B | 3.1B | 3.4B | 3.5B |
| 應收帳款 | 1.1B | 938M | 863M | 771M | 717M | 676M | 569M | 529M | 435M | 309M | 299M | 310M |
| 存貨 | 733M | 682M | 532M | 503M | 495M | 495M | 432M | 443M | 447M | 317M | 321M | 297M |
| 總資產 | 9.2B | 8.6B | 7.6B | 6.3B | 5.8B | 5.9B | 5.8B | 5.7B | 5.7B | 5.5B | 5.7B | 6.0B |
| 有息負債 | 882M | 963M | – | 146M | 160M | 166M | 188M | 185M | 199M | 202M | 207M | 206M |
| 總負債 | 4.0B | 3.8B | 3.5B | 2.5B | 2.3B | 2.6B | 2.4B | 2.3B | 2.3B | 1.8B | 1.9B | 1.8B |
| 股東權益 | 5.2B | 4.8B | 4.1B | 3.8B | 3.5B | 3.3B | 3.4B | 3.4B | 3.4B | 3.8B | 3.8B | 4.2B |
| 負債比 | 43.6% | 44.3% | 45.9% | 40.1% | 40.1% | 43.7% | 41.1% | 41.1% | 40.7% | 31.9% | 33.7% | 30.2% |
| 淨現金(現金 − 有息負債) | 4.2B | 3.8B | – | 2.6B | 2.4B | 2.5B | 2.5B | 2.4B | 2.6B | 2.9B | 3.2B | 3.3B |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 201M | – | – | 44.1M-114% | – | – | – | −309M | – | – | −564M |
| 資本支出 | – | 40.8M | – | – | 56.4M | – | – | – | 157M | – | – | 126M |
| 自由現金流 | – | 161M | – | – | −12.3M-97% | – | – | – | −465M | – | – | −689M |
| 折舊攤銷 | – | 41.1M | – | – | 32.8M | – | – | – | 25.3M | – | – | 20.0M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 10.6% | – | – | -1.1% | – | – | – | -61.9% | – | – | -153.9% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
地區2025 年度 · 5.3B
| 美國 | 2.9B | 53.9% | +47.1% |
|---|---|---|---|
| 中國 | 1.7B | 31.4% | +19.0% |
| 歐洲 | 611M | 11.4% | +68.6% |
| All Other Countries Except China United States Of America And Switzerland | 172M | 3.2% | +118.0% |
產品／服務2025 年度 · 5.3B
| 產品 | 5.3B | 98.9% | +39.8% |
|---|---|---|---|
| Collaboration | 61.0M | 1.1% | +98.6% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 5.3B | +40.2% | 287M | 5.4% | 0.19 | 942M |
| FY2024 | 3.8B | +55.0% | −645M | -16.9% | -0.47 | −633M |
| FY2023 | 2.5B | +73.7% | −882M | -35.9% | -0.65 | −1.7B |
| FY2022 | 1.4B | +20.4% | −2.0B | -141.5% | -1.49 | −1.8B |
| FY2021 | 1.2B | +280.8% | −1.5B | -123.9% | -1.21 | −1.6B |
| FY2020 | 309M | -27.9% | −1.6B | -526.1% | -1.50 | −1.4B |
| FY2019 | 428M | +116.0% | −949M | -221.5% | -1.22 | −840M |
| FY2018 | 198M | – | −674M | -339.9% | -0.93 | −618M |